COSA 2015* , ,
Presentations this author is a contributor to:
Precision medicine for advanced pancreas cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) trial (#268)
3:00 PM
Lorraine Chantrill
Posters1
A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: The P3BEP Trial (ANZUP 1302) (#266)
3:00 PM
Howard Chan
Posters1